Locally recurrent rectal cancer: surgical strategy.
Relapses after "curative resection" of rectal cancer may be localized and thus amenable to surgical treatment. The risk of relapse may be higher than previously believed depending on adequacy and length of follow-up, the diagnostic modalities used, and the number of autopsies performed. Technical refinements such as a distal margin greater than 2 cm, radical pelvic lymphadenectomy, and high ligation of the inferior mesenteric artery at the aorta do not appear to diminish the risk of recurrence. A wider lateral margin and a more complete excision of the mesorectum may be beneficial, but this is yet unproven. Surgery for isolated, locally recurrent lesions should be limited to carefully selected patients and performed in tertiary centers using a team approach. Whether such radical "salvage" procedures are justifiable merits further careful evaluation.
de Azevedo
J P
JP
Division of Radiation Oncology, Mayo Clinic, Rochester, Minnesota 55905.
Dozois
R R
RR
Gunderson
L L
LL
D002272:Carcinoembryonic Antigen / Q000032:analysis; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000601:surgery*; D011379:Prognosis; D012004:Rectal Neoplasms / Q000601:surgery*; D012307:Risk Factors
D002272:Carcinoembryonic Antigen